2008
DOI: 10.1021/jm7015842
|View full text |Cite
|
Sign up to set email alerts
|

Novel γ-Aminobutyric Acid ρ1Receptor Antagonists; Synthesis, Pharmacological Activity and Structure−Activity Relationships

Abstract: Gamma-aminobutyric acid (GABA) analogues based on 4-amino-cyclopent-1-enyl phosphinic acid ( 34- 42) and 3-aminocyclobutane phosphinic acids ( 51, 52, 56, 57) were investigated in order to obtain selective homomeric rho 1 GABA C receptor antagonists. The effect of the stereochemistry and phosphinic acid substituent of these compounds on potency and selectivity within the GABA receptor subtypes was investigated. Compounds of high potency at GABA C rho 1 receptors ( 36, K B = 0.78 microM) and selectivity greater… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
49
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
4
2
1

Relationship

2
5

Authors

Journals

citations
Cited by 38 publications
(50 citation statements)
references
References 79 publications
1
49
0
Order By: Relevance
“…This characteristic of GABA can be utilized to provide selective ligands through the generation of conformationally restricted analogues [69]. In 2008, Hanrahan described the synthesis, the pharmacological activity and structure-activity relationships of restricted phosphinic acid analogues of γ-aminobutyric acid and investigated the three major GABA receptor subtypes [70]. The approach was to replace the carboxylic acid by a bioisostere, the phosphinic acid, known to reduce activity at GABA A receptors (Fig.…”
Section: Conformationally Restrained Isogavacine and 4-acpca Phosphinmentioning
confidence: 99%
See 1 more Smart Citation
“…This characteristic of GABA can be utilized to provide selective ligands through the generation of conformationally restricted analogues [69]. In 2008, Hanrahan described the synthesis, the pharmacological activity and structure-activity relationships of restricted phosphinic acid analogues of γ-aminobutyric acid and investigated the three major GABA receptor subtypes [70]. The approach was to replace the carboxylic acid by a bioisostere, the phosphinic acid, known to reduce activity at GABA A receptors (Fig.…”
Section: Conformationally Restrained Isogavacine and 4-acpca Phosphinmentioning
confidence: 99%
“…After protection of 4-hydroxycyclopentenone with TBDMSCl and subsequent reduction and trapping of the enolate intermediate as the triflate, Kumar et al formed the P-C bond using a pallado-catalyzed coupling reaction for a variety of alkyl-H-phosphinates with 2.5 mol% of Pd(PPh 3 ) 4 [70]. The alkylphosphinate esters were isolated in 76-99% yields using mild conditions.…”
Section: Conformationally Restrained Isogavacine and 4-acpca Phosphinmentioning
confidence: 99%
“…17 (S)-4-ACPBPA 6 is the most potent and selective GABA C receptor antagonist of this series. Interestingly, (S)-4-ACPBPA 6 is a conformationally restricted analogue of the orally active GABA B/C receptor antagonist 3-aminopropyl-n-butylphosphinic acid 7 (CGP36742 or SGS742) (GABA B , GABA C , and GABA A : IC 50 = 38, 62, and 508 μM, respectively).…”
mentioning
confidence: 90%
“…Both reaction pathways proceed in moderate to good overall yield and high diastereomeric excess [389]. Similar methodology has been used for the enantioselective synthesis of the 4-amino-cyclopent-1-enyl phosphinic acid analogs from (R)-and (S)-4-(tert-butyldimethylsilyloxy)cyclopent-1-enyl trifluoromethanesulfonate [390]. Allylic bromination of ethyl cyclohex-3-ene-1-carboxylate (578) gave the unsaturated bromo ester (579) (Scheme 14.157).…”
Section: Cyclobutyl G-amino Acidsmentioning
confidence: 99%